Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis
NCT ID: NCT02759211
Last Updated: 2017-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2016-04-30
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
The Effect of Backward Walking Training on Balance, Gait and Functional Mobility in Patients With Multiple Sclerosis
NCT05505383
The 3-Meter Backward Walk Test in Individuals With Multiple Sclerosis
NCT04753411
Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study
NCT02142946
Lokomat Treadmill Training Effects on MS Gait
NCT00835835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Forwards Walking Group (FWG)
The intervention will consist of three (3), treadmill exercise sessions per week, for eight (8) weeks, for a total of 24 exercise sessions.
Forwards Walking
The Forwards Walking Group will perform forwards walking for the entire treatment intervention.
Backwards Walking Group (BWG)
The intervention will consist of three (3), treadmill exercise sessions per week, for eight (8) weeks, for a total of 24 exercise sessions.
Backwards Walking
The Backwards Walking Group will perform backwards walking for the entire treatment intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Backwards Walking
The Backwards Walking Group will perform backwards walking for the entire treatment intervention.
Forwards Walking
The Forwards Walking Group will perform forwards walking for the entire treatment intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitively able to understand directions and complete protocol (score of 22 or greater on MMSE)
* Signed Consent form approved by the Saint Francis Institutional Review Board
* 18-65 years of age
* PDDS score of 3 to 5 during the past 12 months
* Completion of the 6 minute walk test
* Speaks English (in order to safely complete intervention)
Exclusion Criteria
* Current participation in physical therapy
* Major changes in exercise habits in the past three months
* Has had a relapse, acute Solumedrol treatment, or Acthar treatment in the past two months
* Requires constant bilateral assistance (canes or crutches) for ambulation and/or cannot walk at least 100 meters without resting
* Current self-reported medical history of unstable angina, uncontrolled cardiac dysrhythmias causing symptoms, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus or pulmonary infarction, history of DVT, acute myocarditis or pericarditis, acute systemic infection, uncontrolled hypertension, and uncontrolled diabetes \[11\]
* Participants that cannot adhere to the protocol, have an abnormal response to exercise, or is determined to be unsafe may be withdrawn at the discretion of the Principal Investigator
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Multiple Sclerosis Society
OTHER
Mount Sinai Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Ruiz, DPT
Research Manager, Mandell Center for Multiple Sclerosis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jennifer Ruiz, DPT
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFH-16-27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.